# Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer

> **NCT00295035** · PHASE3 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 100 (—)

## Conditions studied

- Colon Neoplasm

## Interventions

- **DRUG:** CELECOXIB
- **DRUG:** CURCUMIN

## Key facts

- **NCT ID:** NCT00295035
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 100 (—)
- **Last updated:** 2006-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00295035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00295035, "Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00295035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*